Strategic Acquisition Plas-Tech Engineering recently became part of H&T Presspart and is now positioned under a market-leading drug delivery devices division, signaling a potential cross-sell of high-precision components, injections moulding capabilities, and integrated development-to-production services to H&T Presspart’s global customer base.

Expanded Scale With 51-200 employees and a revenue range of 10–25 million, Plas-Tech offers a mid-sized footprint capable of handling both low and high-volume production, presenting opportunities to upsell larger batch manufacturing, tooling, and validation services to medical device firms seeking reliable scale.

Awarded Moulding Recognition as a top injection molder and Wisconsin Manufacturer of the Year reinforces credibility for complex molding projects; leverage this status to target customers needing vetted suppliers for complex pre-fillable syringes, assemblies, and container components.

Equinox Suite Equinox pre-fillable syringe brand highlights a specialization in biologics and high-viscosity formulations; pursue outreach to biotech and pharma manufacturers exploring reliable component sourcing and custom syringe solutions.

Strategic Partnerships Historical collaborations with Schreiner Group and Rapid Robotics indicate openness to ecosystem partnerships; approach potential clients with joint manufacturing or automation capabilities, offering integrated solutions from design through validation.